The retail subscription process, comprising of a maximum of 2,100,000 representing 10% of the total Offer Shares, commenced on Tuesday, 30 May 2023 and ended on Thursday, 01 June 2023
CAUTION - FORWARD LOOKING STATEMENTS Certain statements contained herein regarding the Company and its operations constitute "forward-looking statements" within the. | May 15, 2023
Mankind Pharma s IPO fails to attract enough retail investors, with the retail quota 8% unsubscribed. The company plans to raise ?4,326 crore through the IPO.
Abdullah Al Othaim Investment Company (AOIC), a leading mall, entertainment, fashion and F&B operator in KSA, will offer 30 million ordinary shares through an initial public offering (IPO) and list them on Saudi Exchange’s Main Market.
02.02.2022 - Regulatory News: Not to be distributed, directly or indirectly, in the United States of America, Canada, Australia, Japan or South Africa. Aelis Farma, a clinical-stage biopharmaceutical company specializing in the development of treatments for .